The rising interest in GLP-1 agonists for diabetes has led to a discussion about delivery routes : skin-applied devices versus tablets . Usually , GLP-1 treatments were solely available in tablet form, https://rajanvdbc388225.blogtov.com/21648757/glp-1-transdermal-delivery-systems-vs-oral-medications-what-right-for-you